Literature DB >> 21696087

A systematic review of the worldwide prevalence and incidence of Parkinson's disease.

Weerasak Muangpaisan1, Aju Mathews, Hiroyuki Hori, David Seidel.   

Abstract

BACKGROUND: A number of epidemiologic studies of Parkinson 's disease (PD) have been conducted worldwide over the years. Although every study reported the rise in prevalence and incidence rate of PD with the increasing age, the overall estimates were different across countries. The variation in reported data may partly be contributed by case ascertainment, case finding method, data collection, and most importantly different population structures.
OBJECTIVE: Systematically review prevalence and incidence of PD and find the causes of variation in the results. MATERIAL AND
METHOD: A literature search was conducted on Medline and EMBASE for studies worldwide investigating the prevalence and incidence of PD and included all adults, English and publication between 1965 and January 2010. The primary search of both databases yielded 5,330 results. After screening topics and abstracts, 168 relevant abstracts were tagged and saved for more thorough perusal. Ultimately, 40 papers were selected for review after applying the pre-specified inclusion criteria
RESULTS: The worldwide prevalence of PD varies widely. One reason for the variation in prevalence estimates could be due to the differences in survival across countries. The use of epidemiological studies using medical records could be another reason for the variation in disease frequency.
CONCLUSION: PD is common in the elderly. A number of descriptive epidemiologic studies have been conducted worldwide. Comparing the incidence and prevalence of Parkinson's disease is difficult.

Entities:  

Mesh:

Year:  2011        PMID: 21696087

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  42 in total

1.  Current and projected future economic burden of Parkinson's disease in the U.S.

Authors:  Wenya Yang; Jamie L Hamilton; Catherine Kopil; James C Beck; Caroline M Tanner; Roger L Albin; E Ray Dorsey; Nabila Dahodwala; Inna Cintina; Paul Hogan; Ted Thompson
Journal:  NPJ Parkinsons Dis       Date:  2020-07-09

2.  Converting Parkinson-Specific Scores into Health State Utilities to Assess Cost-Utility Analysis.

Authors:  Gang Chen; Miguel A Garcia-Gordillo; Daniel Collado-Mateo; Borja Del Pozo-Cruz; José C Adsuar; José Manuel Cordero-Ferrera; José María Abellán-Perpiñán; Fernando Ignacio Sánchez-Martínez
Journal:  Patient       Date:  2018-12       Impact factor: 3.883

3.  Using Canadian Primary Care Sentinel Surveillance Network data to examine depression in patients with a diagnosis of Parkinson disease: a retrospective cohort study.

Authors:  Kimberly Rose P Singian; Morgan Price; Vicky Bungay; Sabrina T Wong
Journal:  CMAJ Open       Date:  2016-08-08

Review 4.  Synucleinopathies: common features and hippocampal manifestations.

Authors:  Weiwei Yang; Shun Yu
Journal:  Cell Mol Life Sci       Date:  2016-11-08       Impact factor: 9.261

5.  The tolerability, safety and efficacy of safinamide in elderly Parkinson's disease patients: a retrospective study.

Authors:  Domiziana Rinaldi; Edoardo Bianchini; Michela Sforza; Marika Alborghetti; Silvia Galli; Marco Salvetti; Morena Giovannelli; Francesco E Pontieri
Journal:  Aging Clin Exp Res       Date:  2020-07-17       Impact factor: 3.636

Review 6.  The prevalence and incidence of Parkinson's disease in China: a systematic review and meta-analysis.

Authors:  Chun-lin Ma; Li Su; Juan-juan Xie; Jian-xiong Long; Peng Wu; Lian Gu
Journal:  J Neural Transm (Vienna)       Date:  2013-09-22       Impact factor: 3.575

7.  Microbial-mammalian cometabolites dominate the age-associated urinary metabolic phenotype in Taiwanese and American populations.

Authors:  Jonathan R Swann; Konstantina Spagou; Matthew Lewis; Jeremy K Nicholson; Dana A Glei; Teresa E Seeman; Christopher L Coe; Noreen Goldman; Carol D Ryff; Maxine Weinstein; Elaine Holmes
Journal:  J Proteome Res       Date:  2013-06-24       Impact factor: 4.466

8.  Co-occurring chronic conditions and healthcare expenditures associated with Parkinson's disease: a propensity score matched analysis.

Authors:  Sandipan Bhattacharjee; Usha Sambamoorthi
Journal:  Parkinsonism Relat Disord       Date:  2013-05-13       Impact factor: 4.891

9.  Scientific Rigor Recommendations for Optimizing the Clinical Applicability of Translational Research.

Authors:  Paul A Lapchak
Journal:  J Neurol Neurophysiol       Date:  2012

10.  Genetic polymorphisms in VDR, ESR1 and ESR2 genes may contribute to susceptibility to Parkinson's disease: a meta-analysis.

Authors:  Zhan Gao; Hong-Juan Fu; Ju-Jun Xue; Zhi-Xuan Wu; Li-Bo Zhao
Journal:  Mol Biol Rep       Date:  2014-03-05       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.